4
MARKET OVERVIEW
Covers the key developments, trend analysis, and actionable insights to support strategic planning and positioning.
4.3
UNMET NEEDS & WHITE SPACES
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
THREAT OF SUBSTITUTES
5.1.3
BARGAINING POWER OF SUPPLIERS
5.1.4
BARGAINING POWER OF BUYERS
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC OUTLOOK
5.2.1
GDP TRENDS & FORECAST
5.2.2
TRENDS IN NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET
5.2.3
TRENDS IN NORTH AMERICA HEALTHCARE/PHARMA INDUSTRY
5.4.1
EMERGING BUSINESS MODELS & ECOSYSTEM SHIFTS
5.5.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022–2024)
5.5.2
AVERAGE SELLING PRICE TREND, BY COUNTRY (2022–2024)
5.6
TRADE ANALYSIS (2020–2024)
5.7
KEY CONFERENCES & EVENTS, 2026–2027
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.9
INVESTMENT & FUNDING SCENARIO
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
5.10
IMPACT OF 2025 US TARIFFS ON NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON COUNTRIES/REGIONS
5.10.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1.2
MAGNETIC-BEAD BASED TECHNOLOGY
6.1.3
AUTOMATED PLATFORMS
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.2
SAMPLE HOMOGENIZATION & DISRUPTION SYSTEMS
6.3
ADJACENT TECHNOLOGIES
6.3.1
MICROFLUIDIC EXTRACTION
6.3.2
EXTRACTION-FREE AMPLIFICATION
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.7
IMPACT OF AI/GEN AI ON NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET
6.7.1
TOP USE CASES & MARKET POTENTIAL
6.7.2
CASE STUDIES OF AI IMPLEMENTATION IN NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET
6.7.3
INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS
6.7.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET
7
SUSTAINABILITY & REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
7.3
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET, BY PRODUCT, (MARKET SIZE 2023 – 2030, FORECAST TO 2030 – IN VALUE, USD MILLION)
9.3.1
AUTOMATIC INSTRUMENTS
10
NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET, BY TYPE, 2023-2030 (USD MILLION)
10.2
PLASMID DNA ISOLATION AND PURIFICATION
10.3
TOTAL RNA ISOLATION AND PURIFICATION
10.4
GENOMIC DNA ISOLATION AND PURIFICATION
10.5
MESSENGER RNA ISOLATION AND PURIFICATION
10.6
CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
10.7
MICRORNA ISOLATION AND PURIFICATION
11
NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET, BY METHOD, 2023-2030 (USD MILLION)
11.2
MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
11.3
REAGENT-BASED ISOLATION AND PURIFICATION
11.4
COLUMN-BASED ISOLATION AND PURIFICATION
12
NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
12.3
DRUG DISCOVERY & DEVELOPMENT
12.4
PERSONALIZED MEDICINE
12.5
AGRICULTURE & ANIMAL RESEARCH
13
NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP), BY END USER, 2023-2030 (USD MILLION)
13.2
HOSPITALS & DIAGNOSTIC CENTERS
13.3
ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
13.4
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
13.5
CONTRACT RESEARCH ORGANIZATIONS (CROS)
14
NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP), BY COUNTRY, 2023-2030 (USD MILLION)
14.2.3
MACROECONOMIC OUTLOOK OF NORTH AMERICA
15.2
KEY PLAYER STRATEGY/ RIGHT TO WIN
15.3
REVENUE ANALYSIS, 2022–2024
15.4
MARKET SHARE ANALYSIS,
15.5
COMPANY EVALUATION MATRIX: KEY PLAYERS,
15.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
15.5.5.1
COMPANY FOOTPRINT
15.5.5.2
COUNTRY FOOTPRINT
15.5.5.3
PRODUCT FOOTPRINT
15.5.5.4
APPLICATION FOOTPRINT
15.6
COMPANY EVALUATION MATRIX: START-UPS/SMES,
15.6.1
PROGRESSIVE COMPANIES
15.6.2
RESPONSIVE COMPANIES
15.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
15.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
15.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
15.8
COMPANY VALUATION & FINANCIAL METRICS
15.9
COMPETITIVE SCENARIO
15.9.3
OTHER DEVELOPMENTS
16.1.1THERMO FISHER SCIENTIFIC, INC.
16.1.2
DANAHER CORPORATION
16.1.4
AGILENT TECHNOLOGIES
16.1.6
BIO-RAD LABORATORIES, INC.
16.1.7
F. HOFFMAN-LA ROCHE LTD.
16.1.8
NEW ENGLAND BIOLABS
16.1.9
PROMEGA CORPORATION
NOTE: THE DETAILS ON BUSINESS OVERVIEW, FINANCIAL INFORMATION, PRODUCT PORTFOLIO, RECENT DEVELOPMENTS, AND MARKETSANDMARKETS VIEW WILL BE PROVIDED FOR ~25 COMPANIES. THESE DETAILS MIGHT NOT BE CAPTURED IN THE CASE OF UNLISTED COMPANIES. THE PROVIDED LIST
17.1.1.1
KEY SOURCES OF SECONDARY DATA
17.1.1.2
KEY OBJECTIVES OF SECONDARY DATA
17.1.2.1
BREAKDOWN OF PRIMARIES
17.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
17.2
MARKET SIZE ESTIMATION
17.2.1
NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) SIZE ESTIMATION
17.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
17.2.1.2
MNM REPOSITORY ANALYSIS
17.2.1.3
SECONDARY ANALYSIS
17.2.1.4
PRIMARY RESEARCH
17.2.1.4.1
INSIGHTS FROM PRIMARY EXPERTS
17.2.2
SEGMENTAL MARKET SIZE ESTIMATION (TOP-DOWN APPROACH)
17.3
MARKET GROWTH RATE PROJECTIONS
17.6
RESEARCH ASSUMPTIONS
17.7
RESEARCH LIMITATIONS & RISK ASSESSMENT
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in North America Nucleic Acid Isolation and Purification Market